Authors:
Granath, B
Taylor, RR
van Bockxmeer, FM
Mamotte, CDS
Citation: B. Granath et al., Lack of evidence for association between endothelial nitric oxide synthasegene polymorphisms and coronary artery disease in the Australian Caucasianpopulation, J CARD RISK, 8(4), 2001, pp. 235-241
Authors:
van Bockxmeer, FM
Liu, QH
Mamotte, C
Burke, V
Taylor, R
Citation: Fm. Van Bockxmeer et al., Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids, ATHEROSCLER, 157(1), 2001, pp. 123-129
Authors:
Freitas, EM
Gaudieri, S
Zhang, WJ
Kulski, JK
van Bockxmeer, FM
Christiansen, FT
Dawkins, RL
Citation: Em. Freitas et al., Duplication and diversification of the apolipoprotein CI (APOCI) genomic segment in association with retroelements, J MOL EVOL, 50(4), 2000, pp. 391-396
Authors:
Watts, GF
Riches, FM
Humphries, SE
Talmud, PJ
van Bockxmeer, FM
Citation: Gf. Watts et al., Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity, J LIPID RES, 41(3), 2000, pp. 481-488
Authors:
Brownrigg, LM
Stanton, KG
McCann, VJ
Burke, V
Taylor, RR
van Bockxmeer, FM
Citation: Lm. Brownrigg et al., Increased frequency of the lipoprotein lipase 9N allele in adults with Type I (insulin-dependent) diabetes mellitus, DIABETOLOG, 43(7), 2000, pp. 953-954
Authors:
Eikelboom, JW
Baker, RI
Parsons, R
Taylor, RR
van Bockxmeer, FM
Citation: Jw. Eikelboom et al., No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease, THROMB HAEM, 80(6), 1998, pp. 878-880